Acurx Pharmaceuticals, Inc. today announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 1,333,333 shares of common stock and unregistered Series D warrants to purchase up to an aggregate of 1,333,333 shares of common stock.
